Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Altered	B-Delirium
Mental	B-Delirium
Status	B-Delirium
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Intubation,	O
RIJ	O
History	O
of	O
Present	O
Illness:	O
___	O
year	O
old	O
female	O
with	O
a	O
history	O
of	O
recurrent	O
UTIs,	B-Urinary_tract_infection
HTN,	O
Hyperlipidemia	O
and	O
peripheral	O
vascular	O
disease,	O
presenting	O
from	O
___	O
with	O
UTI,	B-Urinary_tract_infection
sepsis	O
and	O
acute	O
renal	O
failure	O
with	O
hyperkalemia.	O
Notably,	O
the	O
patient	O
was	O
recently	O
discharged	O
from	O
___	O
following	O
treatment	O
for	O
an	O
ESBL	O
UTI	B-Urinary_tract_infection
treated	O
with	O
Ertapenem	O
as	O
an	O
outpatient.	O
Sensitivities	O
showed	O
that	O
the	O
ESBL	O
was	O
sensitive	O
to	O
Zosyn,	O
Penems	O
and	O
Bactrim.	O
Blood	O
cultures	O
from	O
___	O
and	O
___	O
grew	O
ESBL,	O
with	O
cultures	O
from	O
___	O
and	O
___	O
growing	O
staph	O
epidermis.	O
These	O
were	O
all	O
drawn	O
from	O
a	O
PICC	O
which	O
was	O
removed	O
on	O
___	O
after	O
which	O
point	O
the	O
PICC	O
line	O
was	O
removed	O
and	O
subsequent	O
blood	O
cultures	O
were	O
negative.	O
The	O
patient	O
completed	O
a	O
7	O
day	O
course	O
of	O
Vancomycin	O
and	O
a	O
14	O
day	O
course	O
of	O
IM	O
Ertapenem	O
(last	O
dose	O
on	O
___.	O
During	O
that	O
admission,	O
the	O
patient	O
was	O
also	O
noted	O
to	O
have	O
___	O
which	O
resolved	O
and	O
was	O
discharged	O
with	O
a	O
creatinine	O
of	O
0.9.	O
The	O
patient	O
presented	O
to	O
the	O
___	O
from	O
a	O
nursing	B-Lives_in_carehome
home	B-Lives_in_carehome
following	O
2	O
days	O
of	O
altered	B-Delirium
mental	B-Delirium
status.	B-Delirium
The	O
patient's	O
baseline	O
is	O
generally	O
conversant.	O
Here,	O
she	O
was	O
found	O
to	O
have	O
hyperkalemia	O
to	O
6.7,	O
with	O
an	O
EKG	O
showing	O
no	O
changes.	O
Her	O
Cr	O
was	O
also	O
noted	O
to	O
be	O
5.7.	O
She	O
got	O
insulin/Dextrose,	O
Calcium,	O
and	O
100mg	O
IV	O
Lasix.	O
A	O
foley	O
catheter	O
was	O
placed	O
with	O
700ccs	O
of	O
thick	O
white	O
urine	O
output.	O
The	O
patient	O
was	O
given	O
a	O
liter	O
of	O
NS	O
and	O
put	O
out	O
an	O
additional	O
300ccs	O
of	O
urine.	O
She	O
was	O
started	O
on	O
Vancomycin	O
and	O
Ceftriaxone.	O
The	O
patient's	O
repeat	O
potassium	O
was	O
unimproved,	O
she	O
was	O
given	O
a	O
second	O
liter	O
of	O
NS,	O
and	O
there	O
was	O
concern	O
for	O
need	O
for	O
urgent	O
dialysis,	O
so	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
___.	O
Prior	O
to	O
transfer,	O
she	O
had	O
some	O
low	O
MAPs	O
in	O
the	O
___,	O
and	O
a	O
right	O
IJ	O
was	O
placed.	O
In	O
the	O
___	O
at	O
___,	O
the	O
patient	O
was	O
noted	O
to	O
be	O
obtunded,	O
but	O
intermittently	O
awake	O
arousable.	O
She	O
was	O
not	O
intubated	O
as	O
she	O
appeared	O
to	O
be	O
protecting	O
her	O
airway.	O
She	O
was	O
pan	O
cultured	O
and	O
started	O
on	O
Zosyn	O
given	O
her	O
previous	O
ESBL	O
UTI	B-Urinary_tract_infection
which	O
was	O
sensitive.	O
Her	O
potassium	O
was	O
down	O
to	O
5.4	O
with	O
a	O
lactate	O
of	O
2.6,	O
pH	O
of	O
7.2	O
and	O
Bicarb	O
of	O
18.	O
Renal	O
saw	O
the	O
patient	O
and	O
recommended	O
Lasix	O
160	O
and	O
then	O
a	O
drip	O
if	O
no	O
good	O
output	O
in	O
30	O
minutes,	O
repeating	O
K	O
4	O
hours	O
after	O
Lasix,	O
insulin/albuterol	O
for	O
temporizing	O
as	O
well	O
as	O
kayexalate.	O
The	O
patient	O
was	O
given	O
only	O
Zosyn	O
4.5g	O
IV	O
in	O
the	O
___,	O
but	O
no	O
further	O
diuresis	O
or	O
temporizing	O
measures	O
for	O
her	O
K.	O
The	O
patient	O
had	O
some	O
low	O
MAPs	O
in	O
the	O
___	O
in	O
the	O
___	O
and	O
was	O
started	O
on	O
levophed.	O
CXR	O
shoed	O
no	O
pulmonary	O
edema	O
with	O
a	O
CVL	O
at	O
the	O
cavoatrial	O
junction.	O
In	O
___	O
initial	O
VS:	O
T96.7	O
HR98	O
BP101/72	O
RR10	O
O296%	O
Past	O
Medical	O
History:	O
Hip	O
and	O
knee	O
arthroplasty	O
Left	O
toe	O
amputation	O
Dementia	B-Dementia
recurrent	O
UTI	B-Urinary_tract_infection
DMII	O
HTN	O
HLD	O
Depression	O
ESBL	O
UTI	B-Urinary_tract_infection
Peripheral	O
vascular	O
disease	O
Social	O
History:	O
Lives	O
at	O
nursing	B-Lives_in_carehome
home.	B-Lives_in_carehome
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM	O
GENERAL:	O
Unarousable,	O
unable	O
to	O
converse,	O
following	O
some	O
commands	O
HEENT:	O
Sclera	O
anicteric,	O
MMM,	O
oropharynx	O
clear,	O
pupils	O
slugglishly	O
reactive	O
NECK:	O
supple,	O
no	O
JVD	O
LUNGS:	O
Clear	O
to	O
auscultation	O
bilaterally,	O
no	O
wheezes,	O
rales,	O
rhonchi	O
CV:	O
Regular	O
rate	O
and	O
rhythm,	O
normal	O
S1	O
S2,	O
late	O
peaking	O
systolic	O
ejection	O
murmur	O
best	O
heard	O
a	O
right	O
second	O
intercostal	O
space	O
ABD:	O
soft,	O
non-tender,	O
non-distended,	O
bowel	O
sounds	O
present,	O
no	O
rebound	O
tenderness	O
or	O
guarding	O
EXT:	O
Warm,	O
well	O
perfused,	O
2+	O
pulses,	O
no	O
clubbing,	O
cyanosis	O
or	O
edema	O
SKIN:	O
Two	O
stage	O
three	O
pressure	O
ulcers	O
on	O
back	O
NEURO:	O
Mimimally	O
arousable,	O
following	O
some	O
commands	O
intermittently.	O
Withdrawing	O
to	O
pain.	O
CNs	O
intact.	O
Positive	O
gag	O
reflex.	O
DISCHARGE	O
PHYSICAL	O
EXAM	O
VS:	O
98.0	O
140/60	O
98	O
17	O
99	O
Ra	O
GENERAL:	O
Waxing/waning	O
attention,	O
conversant	O
but	O
confused,	O
no	O
agitation	O
this	O
morning	O
HEENT:	O
AT/NC,	O
anicteric	O
sclera	O
HEART:	O
RRR,	O
S1/S2,	O
___	O
systolic	O
murmur,	O
no	O
gallops	O
or	O
rubs	O
LUNGS:	O
CTAB,	O
nonlabored	O
respirations	O
ABDOMEN:	O
nondistended	O
EXTREMITIES:	O
LLE	O
with	O
wrapped	O
chronic	O
ulcer	O
NEURO:	O
AOx1,	O
moving	O
all	O
extremities	O
Pertinent	O
Results:	O
ADMISSION	O
LABS	O
___	O
10:05PM	O
BLOOD	O
WBC-25.9*	O
RBC-3.48*	O
Hgb-8.8*	O
Hct-29.8*	O
MCV-86	O
MCH-25.3*	O
MCHC-29.5*	O
RDW-17.5*	O
RDWSD-53.5*	O
Plt	O
___	O
___	O
10:05PM	O
BLOOD	O
Neuts-82.9*	O
Lymphs-9.5*	O
Monos-5.7	O
Eos-0.0*	O
Baso-0.2	O
Im	O
___	O
AbsNeut-21.44*	O
AbsLymp-2.46	O
AbsMono-1.47*	O
AbsEos-0.01*	O
AbsBaso-0.05	O
___	O
10:05PM	O
BLOOD	O
___	O
PTT-26.1	O
___	O
___	O
12:17AM	O
BLOOD	O
___	O
___	O
10:05PM	O
BLOOD	O
Glucose-192*	O
UreaN-89*	O
Creat-4.5*	O
Na-135	O
K-5.7*	O
Cl-101	O
HCO3-16*	O
AnGap-18	O
___	O
10:05PM	O
BLOOD	O
ALT-9	O
AST-24	O
CK(CPK)-1173*	O
AlkPhos-107*	O
TotBili-0.2	O
___	O
10:05PM	O
BLOOD	O
CK-MB-33*	O
MB	O
Indx-2.8	O
proBNP-537	O
___	O
10:05PM	O
BLOOD	O
Albumin-2.3*	O
Calcium-9.0	O
Phos-7.9*	O
Mg-2.1	O
___	O
10:12PM	O
BLOOD	O
___	O
pO2-45*	O
pCO2-44	O
pH-7.20*	O
calTCO2-18*	O
Base	O
XS--10	O
___	O
10:12PM	O
BLOOD	O
Lactate-2.6*	O
K-5.4*	O
___	O
12:42AM	O
BLOOD	O
Lactate-1.8	O
DISCHARGE	O
LABS	O
___	O
06:46AM	O
BLOOD	O
WBC-9.2	O
RBC-2.94*	O
Hgb-7.5*	O
Hct-24.2*	O
MCV-82	O
MCH-25.5*	O
MCHC-31.0*	O
RDW-17.9*	O
RDWSD-53.2*	O
Plt	O
___	O
___	O
06:46AM	O
BLOOD	O
Glucose-175*	O
UreaN-23*	O
Creat-1.2*	O
Na-147	O
K-4.0	O
Cl-113*	O
HCO3-21*	O
AnGap-13	O
___	O
06:46AM	O
BLOOD	O
Calcium-8.3*	O
Phos-2.5*	O
Mg-1.7	O
MICROBIOLOGY	O
___	O
10:10	O
pm	O
URINE	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
ESCHERICHIA	O
COLI.	O
>100,000	O
CFU/mL.	O
PRESUMPTIVE	O
IDENTIFICATION.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
ESCHERICHIA	O
COLI	O
|	O
AMIKACIN--------------	O
4	O
S	O
AMPICILLIN------------	O
=>32	O
R	O
AMPICILLIN/SULBACTAM--	O
16	O
I	O
CEFAZOLIN-------------	O
=>64	O
R	O
CEFEPIME--------------	O
R	O
CEFTAZIDIME-----------	O
16	O
R	O
CEFTRIAXONE-----------	O
=>64	O
R	O
CIPROFLOXACIN---------	O
=>4	O
R	O
GENTAMICIN------------	O
=>16	O
R	O
MEROPENEM-------------<=0.25	O
S	O
NITROFURANTOIN--------	O
<=16	O
S	O
PIPERACILLIN/TAZO-----	O
8	O
S	O
TOBRAMYCIN------------	O
=>16	O
R	O
TRIMETHOPRIM/SULFA----	O
<=1	O
S	O
___	O
10:10	O
pm	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine	O
(Preliminary):	O
ESCHERICHIA	O
COLI.	O
FINAL	O
SENSITIVITIES.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
ESCHERICHIA	O
COLI	O
|	O
AMIKACIN--------------	O
4	O
S	O
AMPICILLIN------------	O
=>32	O
R	O
AMPICILLIN/SULBACTAM--	O
=>32	O
R	O
CEFAZOLIN-------------	O
=>64	O
R	O
CEFEPIME--------------	O
R	O
CEFTAZIDIME-----------	O
16	O
R	O
CEFTRIAXONE-----------	O
=>64	O
R	O
CIPROFLOXACIN---------	O
=>4	O
R	O
GENTAMICIN------------	O
=>16	O
R	O
MEROPENEM-------------<=0.25	O
S	O
PIPERACILLIN/TAZO-----	O
8	O
S	O
TOBRAMYCIN------------	O
=>16	O
R	O
TRIMETHOPRIM/SULFA----	O
<=1	O
S	O
Anaerobic	O
Bottle	O
Gram	O
Stain	O
(Final	O
___:	O
GRAM	O
NEGATIVE	O
ROD(S).	O
Reported	O
to	O
and	O
read	O
back	O
by	O
___	O
(___)	O
@	O
1432	O
ON	O
___.	O
IMAGING/RESULTS:	O
CXR	O
___:	O
IMPRESSION:	O
Right	O
internal	O
jugular	O
central	O
venous	O
catheter	O
tip	O
at	O
the	O
SVC/right	O
atrial	O
junction.	O
Low	O
lung	O
volumes	O
without	O
acute	O
cardiopulmonary	O
abnormality.	O
TEE	O
___:	O
Conclusions	O
The	O
left	O
atrial	O
volume	O
index	O
is	O
normal.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
normal	O
cavity	O
size.	O
Due	O
to	O
suboptimal	O
technical	O
quality,	O
a	O
focal	O
wall	O
motion	O
abnormality	O
cannot	O
be	O
fully	O
excluded.	O
Left	O
ventricular	O
systolic	O
function	O
is	O
hyperdynamic	O
(EF>75%).	O
Tissue	O
Doppler	O
imaging	O
suggests	O
an	O
increased	O
left	O
ventricular	O
filling	O
pressure	O
(PCWP>18mmHg).	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened	O
but	O
aortic	O
stenosis	O
is	O
not	O
present.	O
No	O
aortic	O
regurgitation	O
is	O
seen.	O
Physiologic	O
mitral	O
regurgitation	O
is	O
seen	O
(within	O
normal	O
limits).	O
The	O
estimated	O
pulmonary	O
artery	O
systolic	O
pressure	O
is	O
normal.	O
There	O
is	O
an	O
anterior	O
space	O
which	O
most	O
likely	O
represents	O
a	O
prominent	O
fat	O
pad.	O
IMPRESSION:	O
Mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
preserved	O
regional/and	O
hyperdynamic	O
global	O
systolic	O
function.	O
Elevated	O
PCWP.	O
Aortic	O
sclerosis	O
without	O
stenosis.	O
CXR	O
___:	O
IMPRESSION:	O
Compared	O
to	O
chest	O
radiographs	O
___.	O
With	O
the	O
chin	O
down,	O
tip	O
of	O
the	O
endotracheal	O
tube,	O
slightly	O
more	O
than	O
2	O
cm	O
from	O
the	O
carina	O
is	O
ax	O
septal.	O
Care	O
should	O
be	O
taken	O
that	O
it	O
not	O
advanced	O
any	O
further.	O
Atelectasis	O
at	O
the	O
lung	O
bases	O
is	O
mild.	O
Upper	O
lungs	O
clear.	O
Normal	O
cardiomediastinal	O
silhouette.	O
No	O
pleural	O
abnormality.	O
Indwelling	O
right	O
jugular	O
line	O
ends	O
in	O
the	O
low	O
SVC.	O
CT	O
HEAD	O
W/O	O
CONTRAST	O
___:	O
IMPRESSION:	O
No	O
acute	O
intracranial	O
process.	O
Brain	O
parenchymal	O
atrophy.	O
Moderate	O
hippocampal	O
atrophy,	O
abnormal	O
for	O
age.	O
Enlarged	O
lacrimal	O
glands	O
bilaterally,	O
may	O
be	O
inflammatory	O
in	O
etiology,	O
lymphoproliferative	O
process	O
or	O
neoplasm	O
is	O
less	O
likely.	O
RENAL	O
US	O
___:	O
IMPRESSION:	O
No	O
hydronephrosis	O
identified..	O
Brief	O
Hospital	O
Course:	O
___	O
year	O
old	O
female	O
with	O
a	O
history	O
of	O
recurrent	O
UTIs,	B-Urinary_tract_infection
HTN,	O
Hyperlipidemia	O
and	O
peripheral	O
vascular	O
disease,	O
presenting	O
from	O
___	O
with	O
UTI,	B-Urinary_tract_infection
sepsis	O
and	O
acute	O
renal	O
failure	O
with	O
hyperkalemia.	O
Upon	O
presentation	O
to	O
the	O
ICU,	O
pt	O
developed	O
worsening	O
acidosis	O
and	O
AMS	B-Delirium
despite	O
BIPAP,	O
and	O
required	O
intubation.	O
Pt	O
was	O
noted	O
to	O
have	O
septic	B-Urinary_tract_infection
shock	O
requiring	O
pressors,	O
likely	O
from	O
urinary	B-Urinary_tract_infection
source,	O
and	O
was	O
treated	O
with	O
meropenem.	O
ACUTE	O
ISSUES:	O
#Septic	O
shock:	O
#ESBL	O
E.	O
Coli	O
UTI:	B-Urinary_tract_infection
#ESBL	O
E.	O
Coli	O
Bacteremia:	O
Likely	O
source	O
is	O
UTI	B-Urinary_tract_infection
given	O
positive	O
UA	O
and	O
history.	O
Renal	O
u/s	O
showed	O
no	O
hydronephrosis.	O
Prior	O
UTIs	B-Urinary_tract_infection
have	O
been	O
ESBL	O
sensitive	O
to	O
Zosyn.	O
Received	O
one	O
dose	O
of	O
Zosyn	O
in	O
the	O
___,	O
as	O
well	O
as	O
one	O
dose	O
of	O
Vancomycin	O
at	O
___.	O
She	O
was	O
transferred	O
to	O
___	O
for	O
critical	O
care.	O
She	O
received	O
IVF	O
and	O
pressors	O
briefly	O
with	O
improvement	O
in	O
BPs.	O
Urine	O
and	O
blood	O
cultures	O
were	O
positive	O
for	O
ESBL	O
E.	O
coli	O
sensitive	O
to	O
meropenem.	O
She	O
was	O
started	O
on	O
IV	O
meropenem	O
on	O
___	O
and	O
will	O
need	O
to	O
complete	O
a	O
14	O
day	O
course	O
(last	O
day	O
___.	O
___	O
#Hyperkalemia:	O
___	O
with	O
Cr	O
of	O
5.7	O
at	O
___.	O
Suspect	O
this	O
is	O
likely	O
secondary	O
to	O
prerenal	O
azotemia	O
vs.	O
ATN	O
given	O
sepsis	O
and	O
hypotension	O
requiring	O
pressor.	O
Potassium	O
of	O
>	O
6	O
at	O
OSH,	O
received	O
insulin	O
and	O
dextrose,	O
down	O
to	O
5.7	O
in	O
___.	O
Patient	O
given	O
fluids	O
with	O
improvement	O
in	O
Cr.	O
K	O
downtrended	O
and	O
normalized,	O
with	O
discharge	O
K	O
of	O
4.0.	O
Cr	O
continued	O
to	O
trend	O
downward,	O
with	O
discharge	O
Cr	O
of	O
1.2.	O
#Acute	O
Ventilatory	O
respiratory	O
failure	O
#Acidosis:	O
The	O
patient	O
presented	O
with	O
a	O
combined	O
metabolic	O
gap	O
acidosis	O
and	O
respiratory	O
acidosis.	O
Gap	O
acidosis	O
likely	O
secondary	O
to	O
uremia	O
and	O
lactic	O
acidosis	O
in	O
the	O
setting	O
of	O
urosepsis.	O
Unable	O
to	O
keep	O
up	O
with	O
respiratory	O
compensation	O
secondary	O
to	O
encephalopathy	O
with	O
PCO2	O
of	O
44	O
and	O
pH	O
down	O
to	O
7.15	O
on	O
BiPAP.	O
Pt	O
was	O
intubated	O
for	O
worsening	O
acidosis	O
and	O
was	O
extubated	O
on	O
___.	O
She	O
required	O
no	O
further	O
oxygen	O
support.	O
Her	O
acidosis	O
improved	O
with	O
treatment	O
of	O
infection	O
and	O
fluid	O
resuscitation.	O
#Encephalopathy:	O
Most	O
likely	O
toxic	O
metabolic	O
in	O
the	O
setting	O
of	O
infection,	O
hospitalization,	O
metabolic	O
derangements,	O
meds,	O
poor	O
sleep,	O
and	O
pain.	O
CT	O
showed	O
no	O
acute	O
intracranial	O
process.	O
EEG	O
revealed	O
no	O
seizure	O
activity.	O
Patient's	O
mental	O
status	O
improved	O
with	O
treatment	O
of	O
bacteremia.	O
Per	O
patient's	O
family,	O
patient	O
was	O
at	O
baseline	O
mentally	O
at	O
time	O
of	O
discharge.	O
#Anemia:	O
Anemia	O
below	O
baseline	O
with	O
no	O
concerns	O
for	O
active	O
bleeding.	O
Hb	O
was	O
stable	O
and	O
she	O
required	O
no	O
transfusions.	O
Discharge	O
Hb	O
is	O
7.5.	O
#Diabetes	O
type	O
II:	O
Patient	O
had	O
episodes	O
of	O
hypoglycemia	O
on	O
home	O
Lantus	O
dose.	O
It	O
was	O
discontinued	O
and	O
patient	O
was	O
placed	O
on	O
insulin	O
sliding	O
scale.	O
She	O
will	O
be	O
discharged	O
on	O
insulin	O
sliding	O
scale.	O
She	O
should	O
be	O
restarted	O
on	O
home	O
Lantus	O
at	O
a	O
reduced	O
dose	O
if	O
oral	O
intake	O
increases.	O
#Troponinemia:	O
Mild	O
troponinemia	O
with	O
EKG	O
not	O
showing	O
dynamic	O
changes.	O
Unlikely	O
acute	O
plaque	O
rupture,	O
and	O
more	O
likely	O
demand.	O
Trops	O
trended	O
to	O
peak.	O
Patient	O
remained	O
without	O
any	O
chest	O
pain.	O
CHRONIC	O
ISSUES	O
#PVD:	O
Continue	O
home	O
ASA	O
and	O
Plavix	O
#Depression:	O
Continue	O
home	O
fluoxetine	O
#HTN:	O
Hold	O
home	O
antihypertensives	O
in	O
the	O
setting	O
of	O
septic	O
shock.	O
TRANSITIONAL	O
ISSUES:	O
[]	O
She	O
will	O
need	O
to	O
continue	O
IV	O
meropenem	O
until	O
___	O
to	O
complete	O
14	O
day	O
course	O
[]	O
Consider	O
restarting	O
Lantus	O
at	O
lower	O
dose	O
as	O
po	O
intake	O
improves	O
[]	O
Consider	O
increasing	O
gabapentin	O
dosage	O
as	O
kidney	O
function	O
improves	O
[]	O
Consider	O
adjusting	O
oxycodone	O
for	O
further	O
pain	O
management	O
#CONTACT:	O
HCP:	O
___	O
(Son)	O
___	O
#CODE:	O
Full,	O
confirmed	O
with	O
MOLST	O
I	O
have	O
seen	O
and	O
examined	O
Ms.	O
___,	O
reviewed	O
the	O
findings,	O
data,	O
and	O
discharge	O
plan	O
of	O
care	O
documented	O
by	O
Dr.	O
___,	O
MD	O
dated	O
___	O
and	O
agree,	O
except	O
for	O
any	O
additional	O
comments	O
below.	O
Day	O
of	O
discharge	O
management:	O
>	O
30	O
minutes	O
___,	O
MD,	O
PharmD	O
Section	O
of	O
Hospital	O
Medicine	O
___	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
2.	O
Cyanocobalamin	O
500	O
mcg	O
PO	O
DAILY	O
3.	O
Ascorbic	O
Acid	O
___	O
mg	O
PO	O
BID	O
4.	O
Gabapentin	O
300	O
mg	O
PO	O
TID	O
5.	O
amLODIPine	O
5	O
mg	O
PO	O
DAILY	O
6.	O
Acetaminophen	O
1000	O
mg	O
PO	O
TID	O
7.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
8.	O
Mirtazapine	O
15	O
mg	O
PO	O
QHS	O
9.	O
Meladox	O
(melatonin)	O
3	O
mg	O
oral	O
QHS	O
10.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
11.	O
OxyCODONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
TID	O
12.	O
OxyCODONE	O
(Immediate	O
Release)	O
10	O
mg	O
PO	O
DAILY:PRN	O
Pain	O
-	O
Severe	O
13.	O
Lisinopril	O
20	O
mg	O
PO	O
DAILY	O
14.	O
FLUoxetine	O
30	O
mg	O
PO	O
DAILY	O
15.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
16.	O
Glargine	O
16	O
Units	O
Bedtime	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
Novolog	O
Insulin	O
Discharge	O
Medications:	O
1.	O
Bisacodyl	O
10	O
mg	O
PO/PR	O
DAILY	O
Constipation	B-Constipation
2.	O
Meropenem	O
500	O
mg	O
IV	O
Q8H	O
Duration:	O
10	O
Days	O
Last	O
day	O
of	O
therapy	O
-	O
___.	O
Senna	O
8.6	O
mg	O
PO	O
BID	O
Constipation	B-Constipation
4.	O
Gabapentin	O
100	O
mg	O
PO	O
TID	O
5.	O
Insulin	O
SC	O
Sliding	O
Scale	O
Fingerstick	O
QACHS	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
HUM	O
Insulin	O
6.	O
OxyCODONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
Q4H:PRN	O
Pain	O
-	O
Moderate	O
RX	O
*oxycodone	O
5	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
four	O
(4)	O
hours	O
Disp	O
#*18	O
Tablet	O
Refills:*0	O
7.	O
Acetaminophen	O
1000	O
mg	O
PO	O
TID	O
8.	O
Ascorbic	O
Acid	O
___	O
mg	O
PO	O
BID	O
9.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
10.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
11.	O
Cyanocobalamin	O
500	O
mcg	O
PO	O
DAILY	O
12.	O
FLUoxetine	O
30	O
mg	O
PO	O
DAILY	O
13.	O
Meladox	O
(melatonin)	O
3	O
mg	O
oral	O
QHS	O
14.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
15.	O
Mirtazapine	O
15	O
mg	O
PO	O
QHS	O
16.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
17.	O
HELD-	O
amLODIPine	O
5	O
mg	O
PO	O
DAILY	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
amLODIPine	O
until	O
you	O
are	O
evaluated	O
by	O
your	O
doctor.	O
18.	O
HELD-	O
Lisinopril	O
20	O
mg	O
PO	O
DAILY	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Lisinopril	O
until	O
___	O
resolves.	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
PRIMARY	O
DIAGNOSES:	O
ESBL	O
E.	O
coli	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection	B-Urinary_tract_infection
ESBL	O
E.	O
coli	O
bacteremia	O
Toxic	O
metabolic	O
encephalopathy	O
Dementia	B-Dementia
Acute	O
Kidney	O
Injury	O
Anemia	O
SECONDARY	O
DIAGNOSES:	O
Diabetes	O
Mellitus	O
Peripheral	O
Vascular	O
Disease	O
Depression	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Confused	B-Dementia
-	O
always.	O
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Out	O
of	O
Bed	O
with	O
assistance	B-Bed_Chairbound
to	B-Bed_Chairbound
chair	B-Bed_Chairbound
or	O
wheelchair.	B-Mobile_with_aid
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
___.	O
WHY	O
DID	O
YOU	O
COME	O
TO	O
THE	O
HOSPITAL?	O
-	O
You	O
came	O
to	O
the	O
hospital	O
with	O
a	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection.	B-Urinary_tract_infection
WHAT	O
HAPPENED	O
WHILE	O
YOU	O
WERE	O
HERE?	O
-	O
You	O
were	O
found	O
to	O
have	O
bacteria	O
in	O
your	O
urine	O
and	O
blood.	O
You	O
were	O
started	O
on	O
antibiotics	O
to	O
kill	O
the	O
bacteria.	O
-	O
You	O
were	O
found	O
to	O
be	O
short	O
of	O
breath	O
and	O
required	O
a	O
breathing	O
tube.	O
This	O
was	O
removed	O
once	O
it	O
was	O
no	O
longer	O
necessary.	O
-	O
Your	O
kidney	O
function	O
was	O
decreased	O
due	O
to	O
the	O
infection.	O
It	O
was	O
monitored	O
and	O
improved	O
during	O
your	O
hospitalization.	O
-	O
Your	O
memory	O
was	O
initially	O
worsened	O
due	O
to	O
the	O
infection.	O
It	O
improved	O
with	O
the	O
antibiotics.	O
WHAT	O
SHOULD	O
YOU	O
DO	O
WHEN	O
YOU	O
LEAVE	O
THE	O
HOSPITAL?	O
-	O
Please	O
continue	O
to	O
take	O
all	O
of	O
your	O
medications	O
as	O
directed,	O
and	O
follow	O
up	O
with	O
all	O
of	O
your	O
doctors.	O
Again,	O
it	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you!	O
Sincerely,	O
Your	O
___	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

